MIDATECH PHARMA
Media
Sep 6, 2017
Midatech to present at 19th Annual Rodman & Renshaw Global Investment Conference

Midatech Pharma (AIM: MTPH, Nasdaq: MTP), the international specialty pharmaceutical company focused on developing and... read more >

Sep 4, 2017
Midatech submits MTD201 CTA filing for first in human study in carcinoid cancer and acromegaly

Midatech on track to start clinical development with MTD201 in Q4 2017

Midatech Pharma (AIM: MTPH,... read more >

Jul 26, 2017
Completion of pre-clinical liver cancer programme

Midatech Pharma (AIM: MTPH, Nasdaq: MTP), the international specialty pharmaceutical company focused on developing and... read more >

Jul 18, 2017
Trading Update and Notice of Results

Midatech Pharma (AIM: MTPH, Nasdaq: MTP), the international specialty pharmaceutical company focused on developing and... read more >

Jun 13, 2017
R&D manufacturing site visit for investors and analysts

Midatech Pharma (AIM: MTPH; Nasdaq: MTP), the international specialty pharmaceutical company focused on commercialising and developing products... read more >

Jun 9, 2017
Midatech signs global license agreement to investigate panobinostat for treatment of brain cancers

Midatech Pharma (AIM: MTPH; Nasdaq: MTP), the international specialty pharmaceutical company focused on commercialising and developing products... read more >

May 22, 2017
Midatech announces progress update on brain cancer therapies

Midatech Pharma (AIM: MTPH, Nasdaq: MTP), the international specialty pharmaceutical company focused on developing and commercialising products... read more >

Apr 11, 2017
Notice of Annual General Meeting 2017
Apr 4, 2017
Audited financial results for the year ended 31 December 2016

Midatech Pharma (AIM: MTPH; Nasdaq: MTP), the international specialty pharmaceutical company focused on commercialising and developing products... read more >

Mar 10, 2017
Midatech Announces Successful Initial Scale-Up of Its Sustained Release Manufacturing Facility

~ Q-Octreotide will become Midatech’s first Sustained Release product candidate manufactured in house at its state-of-the-art... read more >

Jan 20, 2017
Trading Update

Midatech Pharma (AIM: MTPH, Nasdaq: MTP), the international specialty pharmaceutical company focused on developing and... read more >

 

Media
Sep 6, 2017
Midatech to present at 19th Annual Rodman & Renshaw Global Investment Conference

Midatech Pharma (AIM: MTPH, Nasdaq: MTP), the international specialty pharmaceutical company focused on developing and... read more >

Sep 4, 2017
Midatech submits MTD201 CTA filing for first in human study in carcinoid cancer and acromegaly

Midatech on track to start clinical development with MTD201 in Q4 2017

Midatech Pharma (AIM: MTPH,... read more >

Jul 26, 2017
Completion of pre-clinical liver cancer programme

Midatech Pharma (AIM: MTPH, Nasdaq: MTP), the international specialty pharmaceutical company focused on developing and... read more >

Jul 18, 2017
Trading Update and Notice of Results

Midatech Pharma (AIM: MTPH, Nasdaq: MTP), the international specialty pharmaceutical company focused on developing and... read more >

Jun 13, 2017
R&D manufacturing site visit for investors and analysts

Midatech Pharma (AIM: MTPH; Nasdaq: MTP), the international specialty pharmaceutical company focused on commercialising and developing products... read more >

Jun 9, 2017
Midatech signs global license agreement to investigate panobinostat for treatment of brain cancers

Midatech Pharma (AIM: MTPH; Nasdaq: MTP), the international specialty pharmaceutical company focused on commercialising and developing products... read more >

May 22, 2017
Midatech announces progress update on brain cancer therapies

Midatech Pharma (AIM: MTPH, Nasdaq: MTP), the international specialty pharmaceutical company focused on developing and commercialising products... read more >

Apr 11, 2017
Notice of Annual General Meeting 2017
Apr 4, 2017
Audited financial results for the year ended 31 December 2016

Midatech Pharma (AIM: MTPH; Nasdaq: MTP), the international specialty pharmaceutical company focused on commercialising and developing products... read more >

Mar 10, 2017
Midatech Announces Successful Initial Scale-Up of Its Sustained Release Manufacturing Facility

~ Q-Octreotide will become Midatech’s first Sustained Release product candidate manufactured in house at its state-of-the-art... read more >

Jan 20, 2017
Trading Update

Midatech Pharma (AIM: MTPH, Nasdaq: MTP), the international specialty pharmaceutical company focused on developing and... read more >

© Copyright 2017 Midatech Pharma PLC